GPGI, Inc. Earnings Call Transcripts
Fiscal Year 2026
-
Panelists emphasized resilient economic conditions, the importance of hands-on leadership, and a disciplined, growth-focused investment model. Their strategy leverages permanent capital and operational expertise to acquire and scale high-quality businesses, aiming for sustained outperformance and broad industry reach.
Fiscal Year 2025
-
GPGI reported strong FY2025 results, with CompoSecure and Husky both delivering sales growth and operational improvements. FY2026 guidance calls for 8.5% net sales growth and 17% adjusted EBITDA growth, with margin expansion expected as operational initiatives mature.
-
Q3 saw 13% net sales growth and a 30% EBITDA increase, with gross margin rising to 59%. Guidance for 2025 and 2026 was raised, and a $5B Husky Technologies acquisition was announced, expected to be highly accretive and to diversify revenue.
-
Q2 2025 saw 10% net sales growth and 26% EBITDA growth, with margin expansion from operational efficiencies. Full-year guidance was raised, reflecting strong domestic demand, new program launches, and continued investments, while the M&A pipeline remains robust.
-
Q1 2025 net sales were flat at $103.9M, with adjusted EBITDA down 2% and EPS up to $0.25. The company reaffirmed mid-single-digit growth guidance for 2025, citing strong program wins, record Arculus results, and early benefits from operational improvements.
Fiscal Year 2024
-
2024 saw 8% net sales growth, strong free cash flow, and a 60% reduction in net debt. Arculus achieved its first positive net contribution, and the Resolute Holdings spinoff positions the business for further growth and M&A. Guidance calls for mid-single-digit growth in 2025.
-
Q3 2024 saw double-digit net sales and adjusted EBITDA growth, led by international demand and new card programs. Guidance for 2024 was revised upward, with investments in M&A and efficiency initiatives. The Resolute transaction unlocked $20M in annual free cash flow.
-
Q2 net sales hit a record $108.6M, up 10% year-over-year, with adjusted EBITDA up 8% to $40M. A strategic transaction with the David Cote family will simplify share structure and add $20M+ in annual free cash flow. FY2024 guidance was raised to reflect strong domestic and rebounding international growth.